A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00912899 · TERMINATED

Trial details

NCT number: NCT00912899
Sponsor: Cougar Biotechnology, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Multiple Myeloma

Start date: 2007-12-01
Primary completion: 2010-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.